Clay Northam Wealth Management’s ROBO Global Healthcare Technology and Innovation ETF HTEC Stock Holding History

Clay Northam Wealth Management’s Portfolio HTEC Stock Details HTEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$578K	Buy	17,500 +400	+2%	+$14.1K	0.32%	51
2025 Q4	$604K	Sell	17,100 -535	-3%	-$18.2K	0.34%	48
2025 Q3	$544K	Sell	17,635 -180	-1%	-$5.33K	0.31%	49
2025 Q2	$508K	Sell	17,815 -3,130	-15%	-$84.3K	0.32%	49
2025 Q1	$572K	Buy	20,945 +400	+2%	+$11.8K	0.4%	43
2024 Q4	$593K	Sell	20,545 -900	-4%	-$26.3K	0.38%	40
2024 Q3	$637K	Buy	21,445 +395	+2%	+$11.3K	0.44%	34
2024 Q2	$573K	Sell	21,050 -465	-2%	-$12.7K	0.43%	37
2024 Q1	$612K	Buy	21,515 +185	+0.9%	+$5.16K	0.49%	33
2023 Q4	$598K	Hold	21,330	–	–	0.53%	30
2023 Q3	$539K	Hold	21,330	–	–	0.53%	31
2023 Q2	$642K	Buy	21,330 +200	+0.9%	+$5.97K	0.61%	25
2023 Q1	$630K	Buy	21,130 +25	+0.1%	+$752	0.65%	25
2022 Q4	$610K	Hold	21,105	–	–	0.7%	25
2022 Q3	$571K	Hold	21,105	–	–	0.71%	27
2022 Q2	$611K	Sell	21,105 -5,665	-21%	-$175K	0.76%	27
2022 Q1	$975K	Buy	26,770 +5,870	+28%	+$217K	0.99%	23
2021 Q4	$911K	Buy	+20,900	New	+$934K	0.86%	26

Other funds holding HTEC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

EIP

Ellis Investment Partners Berwyn, Pennsylvania $576M AUM 16.04% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Clay Northam Wealth Management's HTEC Position: Q1 2026 in Review

Clay Northam Wealth Management increased its ROBO Global Healthcare Technology and Innovation ETF (HTEC) stake by 2.3% in Q1 2026, buying an estimated $14.1K and bringing the position to 17,500 shares worth $578K. The position accounts for 0.32% of the portfolio, ranked #51.

Clay Northam Wealth Management first reported a position in HTEC in Q4 2021 and has held it in 18 quarters since. The position peaked at $975K in Q1 2022. 27 funds tracked by Wall St. Rank hold HTEC as of Q1 2026.

Clay Northam Wealth Management held 17,500 shares of ROBO Global Healthcare Technology and Innovation ETF worth $578K as of Q1 2026.
Clay Northam Wealth Management bought 400 ROBO Global Healthcare Technology and Innovation ETF shares in Q1 2026, an estimated $14.1K.
ROBO Global Healthcare Technology and Innovation ETF made up 0.32% of Clay Northam Wealth Management's portfolio in Q1 2026, its #51 holding.
Clay Northam Wealth Management first reported a position in ROBO Global Healthcare Technology and Innovation ETF in Q4 2021 and has held it in 18 quarters since.
Clay Northam Wealth Management's ROBO Global Healthcare Technology and Innovation ETF position peaked at $975K in Q1 2022.
27 funds tracked by Wall St. Rank held ROBO Global Healthcare Technology and Innovation ETF as of Q1 2026.

Based on Clay Northam Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.